21st week of 2010 patent applcation highlights part 36 |
Patent application number | Title | Published |
20100129429 | INHIBITION OF AUTOPHAGY GENES IN CANCER CHEMOTHERAPY - There is provided compositions and methods for improving the therapeutic efficacy of various cancer treatments, for example endocrine therapy, chemotherapy or radiation therapy, by inhibiting the expression of one or more genes involved in the cellular autophagy response. The compositions include compositions comprising an siRNA directed against an Atg gene and may be used to inhibit expression of an Atg gene in a cell currently undergoing cancer therapy, or to treat, inhibit or prevent cancer in a subject in combination with a cancer therapy. | 2010-05-27 |
20100129430 | LIPOSOME DRUG CARRIERS WITH PH-SENSITIVITY - Using liposomes to deliver bioactive agents to cancer or tumor cells and compositions of specific lipids that form liposomes to deliver a biologically active agent. A liposome composition for delivering of a biologically active agent, comprising liposomes comprising at a least first rigid lipid and a second rigid lipid each having a head group and a hydrophobic tail; a polyethyleneglycol-linked lipid having a side chain matching at least a portion of the first or the second lipid; and an entrapped biologically active agent. The first lipid can be a zwitterionic lipid and the second lipid can have a titratable head group. The composition can be adapted to release the entrapped at a certain pH. | 2010-05-27 |
20100129431 | IDEBENONE COMPOSITION FOR THE TREATMENT OF NEUROLOGICAL DISORDERS - The invention describes the use of an injectable form of Idebenone to induce protect from neuronal damage, improve recovery after brain trauma; stroke, intoxication, neurodegenerative diseases, memory loss or neuropathology associated with neuroinflammation or infection damage and to restore cognitive function, suppress disorientation, alcoholic and drug abuse associated syndromes and other signs of neuronal damage. | 2010-05-27 |
20100129432 | MICROORGANISM-KILLING COMBINATION - The invention is directed to a microorganism-killing combination comprising a photosensitizer in an amount effective to kill microorganisms in a photodynamic process and a chitosan in an amount effective to enhance the microorganism-killing effect of the photosensitizer in the photodynamic process. The invention also provides the methods of administering the synergistic bacteria-killing combination to kill bacteria or treat infection. | 2010-05-27 |
20100129433 | Proteoliposome, Production Method Thereof, and Biochip - A proteoliposome, which is obtained by removing a surfactant from a mixed solution including lipid, membrane proteins and the surfactant, wherein the content of the surfactant in the mixed solution is equal to or more than 1.5 times of the sum of a maximum amount of the surfactant associating with the lipid and a maximum amount of the surfactant associating with the membrane protein. A biochip wherein the above-described proteoliposome is spread on a substrate. A method for producing a proteoliposome by removing a surfactant from a mixed solution including lipid, membrane proteins and the surfactant, wherein the content of the surfactant in the mixed solution is made equal to or more than the sum of a maximum amount of the surfactant associating with the lipid and a maximum amount of the surfactant associating with the membrane protein. | 2010-05-27 |
20100129434 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF MUCORMYCOSIS AND OTHER FUNGAL DISEASES - The invention provides a composition including at least one iron chelating compound and at least one antifungal agent. The composition can include the iron chelating compounds deferiprone or deferasirox. An antifungal agent included in the composition can include a polyene antifungal agent, an azole antifungal agent or an echinocandin antifungal agent. The invention also provides a method of treating or preventing a fungal condition. The method includes administering to an individual having, or susceptible to having, a fungal condition a therapeutically effective amount of at least one iron chelating compound for a sufficient time to reduce the severity of a fungal condition, wherein the iron chelating compound comprises a non-siderophore or non-xenosiderophore relative to the fungal condition. A method of treating or preventing a fungal condition provided by the invention also can include administering to an individual having, or susceptible of having, a fungal condition a therapeutically effective amount of at least one iron chelating compound and at least one antifungal agent. Provided further by the invention is a method including prophylactic administration of the at least one iron chelating compound or at least one iron chelating compound and at least one antifungal agent prior to onset of the fungal condition. | 2010-05-27 |
20100129435 | Methods and compositions for treatment of ocular neovascularization and neural injury - Methods and compositions for the treatment of ocular neovascularization and macular degeneration. The invention includes combining photodynamic therapy with administration of a neuroprotectant and a neovascularization inhibitor. | 2010-05-27 |
20100129436 | SUBTANCES FOR THE PROTECTION OF CELLS AND/OR TISSUES - The invention relates to substances that are suitable for protecting cells and/or tissues. | 2010-05-27 |
20100129437 | TARGETED INTRACELLULAR DELIVERY OF ANTIVIRAL AGENTS - The invention relates to methods of targeted drug delivery of antiviral compounds, including, chemical agents (like nucleoside analogs or protease inhibitors) and nucleic acid based drugs (like DNA vaccines, antisense oligonucleotides, ribozymes, catalytic DNA (DNAzymes) or RNA molecules, siRNAs or plasmids encoding thereof). Furthermore, the invention relates to targeted drug delivery of antiviral compounds to intracellular target sites within cells, tissues and organs, in particular to target sites within the central nervous system (CNS), into and across the blood-brain barrier, by targeting to internalizing uptake receptors present on these cells, tissues and organs. Thereto, the antiviral compounds, or the pharmaceutical acceptable carrier thereof, are conjugated to ligands that facilitate the specific binding to and internalization by these receptors. | 2010-05-27 |
20100129438 | Methods and Compositions for the Treatment and Prevention of HIV Infection Using TRIM5ALPHA - The invention provides novel TRIM polypeptides, proteins, and nucleic acid molecules. In addition to isolated, full-length TRIM proteins, the invention further provides isolated TRIM fusion proteins, antigenic peptides and anti-TRIM antibodies. The invention also provides TRIM nucleic acid molecules, recombinant expression vectors containing a nucleic acid molecule of the invention, host cells into which the expression vectors have been introduced and non-human transgenic animals in which an TRIM gene has been introduced or disrupted. The present invention also provides methods and compositions for the diagnosis and treatment of viral infection and/or replication, e.g., HIV infection. The invention further provides methods for identifying a compound capable of treating or preventing viral infection and/or replication, e.g., HIV infection and AIDS. In addition, the invention provides a method for treating a subject having a viral infection and/or replication, e.g., HIV infection using the modulators of the invention. | 2010-05-27 |
20100129439 | Adjuvant Incorporation in Immunonanotherapeutics - The present invention provides compositions and systems for delivery of nanocarriers to cells of the immune system. The invention provides nanocarriers capable of stimulating an immune response in T cells and/or in B cells. The invention provides nanocarriers that comprise an immunofeature surface and an immunostimulatory moiety. In some embodiments, the immunostimulatory moiety is an adjuvant. The invention provides pharmaceutical compositions comprising inventive nanocarriers. The present invention provides methods of designing, manufacturing, and using inventive nanocarriers and pharmaceutical compositions thereof. | 2010-05-27 |
20100129440 | EMBRYONIC-LIKE STEM CELLS DERIVED FROM ADULT HUMAN PERIPHERAL BLOOD AND METHODS OF USE - The present invention is related generally to embryonic-like stem cells isolated from adult human peripheral blood, designated herein as peripheral blood-stem cells (PB-SC), which display the characteristics of embryonic stem cells and hematopoietic cells. These cells have the capability of proliferation and are able to differentiate to other types of cells. These cells are, therefore, suitable for use in stem cell-based therapies, particularly autologous stem cell therapies, for the treatment of various diseases such as neurodegenerative diseases, autoimmune diseases, diabetes, spinal cord damage, multiple sclerosis, cardiovascular disease, stroke and birth defects. | 2010-05-27 |
20100129441 | Pharmaceutical compositions comprising entacapone, levodopa, and carbidopa - The present invention relates to stable pharmaceutical compositions comprising entacapone, levodopa and carbidopa, or pharmaceutically acceptable salts or hydrates thereof. The invention also relates to processes for the preparation of such compositions. | 2010-05-27 |
20100129442 | Oral Multi-Functional Pharmaceutical Capsule Preparations Of Proton Pump Inhibitors - An oral pharmaceutical composition comprises multiple populations of at least one of beads, pellets, tablets and granules provided in a capsule, the composition comprising: a first population of a pharmaceutical active comprising a pharmaceutical active substance releasable at a first rate; a population of a basic substance; and a second population of a pharmaceutical active comprising a pharmaceutical active substance releasable at a second rate. In another embodiment, the oral pharmaceutical composition comprises multiple populations of at least one of beads, pellets, tablets and granules provided in a capsule, the composition comprising: a population of a pharmaceutical active; a population of a basic substance; a population of enteric coated pharmaceutical active; and a population of enteric coated basic substance. The composition can provide multiple site specific delivery of a pharmaceutical active in a rapid, delayed and/or sustained release manner into the plasma. | 2010-05-27 |
20100129444 | Novel Pharmaceutical Formulations of Modafinil - The present invention is related to compositions of modafinil, including compositions of modafinil and one or more diluents, disintegrants, binders and lubricants, and the processes for their preparation thereof. | 2010-05-27 |
20100129445 | GASTRORETENTIVE SYSTEM COMPRISING AN ALGINATE BODY - Gastroretentive systems which have at least one release device for at least one active pharmaceutical ingredient and at least one swelling body that is connected to the release device. | 2010-05-27 |
20100129446 | SOLID DOSAGE FORMS COMPRISING AN ENTERIC COATING WITH ACCELERATED DRUG RELEASE - The present invention refers to a solid dosage form comprising an inner coating located between a core containing a pharmaceutically active ingredient and an outer enteric coating; wherein said inner coating comprises a partially neutralized anionic polymeric material, and at least a carboxylic acid having 2 to 16 carbon atoms the salts thereof or mixtures of said acid and its salt; wherein said outer coating comprises an anionic polymeric material which is less or not at all neutralized than the material of the inner coating. | 2010-05-27 |
20100129447 | NANOPARTICLES COMPRISING A CHOLESTERYL ESTER TRANSFER PROTEIN INHIBITOR AND ANON-IONIZABLE POLYMER - A pharmaceutical composition comprises nanoparticles comprising a cholesteryl ester transfer protein inhibitor and a poorly aqueous soluble non-ionizable polymer. | 2010-05-27 |
20100129448 | TOPICAL HYDROGEL COMPOSITION - Compositions for topical application to the skin and/or a wound are disclosed. In some embodiments, the compositions include a suspension or dispersion of particles of at least one poorly soluble drug chelated or otherwise complexed with a metal salt. The compositions may further contain at least one stabilizer, at least one excipient, and at least one physiologically acceptable carrier. Methods for making such compositions, pharmaceutical formulations containing such compositions, and methods of treatment utilizing such compositions are also disclosed. | 2010-05-27 |
20100129449 | Cosmetic Neurotoxin Compositions and Methods - Cosmetic compositions include a Clostridial neurotoxin component and a microsphere component. In certain compositions, the composition includes a | 2010-05-27 |
20100129450 | Electrospun Cell Matrices - The invention is directed to compositions and methods for preparing electrospun matrices comprising at least one natural biological material component and at least one synthetic polymer material. The natural component makes the matrices highly biocompatible while the molecular weight polymer component can impart additional strength mechanical strength to the scaffold and/or improve ease of manufacture by increasing viscosity and spinning characteristics of the solution during electrospining. | 2010-05-27 |
20100129451 | Method for preparing hydro/organo gelators from disaccharide sugars by biocatalysis and their use in enzyme-triggered drug delivery - A method for preparing hydro/organo gelators from disaccharide sugars by biocatalysis and their use in enzyme-triggered drug delivery. Controlled delivery of an anti-inflammatory, chemopreventive drug is achieved by an enzyme-triggered drug release mechanism via degradation of encapsulated hydrogels. The hydro- and organo-gelators are synthesized in high yields from renewable resources by using a regioselective enzyme catalysis and a known chemopreventive and anti-inflammatory drug, curcumin, is encapsulated in the gel matrix and released by enzyme triggered delivery. The release of the drug occurs at the physiological temperature and control of the drug release rate is achieved by manipulating the enzyme concentration and temperature. The by-products formed after the gel degradation clearly demonstrated the site specificity of degradation of the gelator by enzyme catalysis. The present invention has applications in developing cost effective, controlled drug delivery vehicles from renewable resources, with a potential impact on pharmaceutical research and molecular design and delivery strategies. | 2010-05-27 |
20100129452 | CELLULOSE DERIVATIVE AND METHOD FOR PRODUCTION THEREOF - The invention provides a cellulose derivative having a repeating unit of the formula below, a composition including the cellulose derivative and a phospholipid, a method for production thereof, and an adhesion barrier including the cellulose derivative or the composition. | 2010-05-27 |
20100129453 | EMULSIONS COMPRISING RUBBER ARABICUM - The invention relates to micelles, micellar solutions and pre-concentrates of emulsions comprising active ingredient and Gum Arabic; products comprising such micelles or pre-concentrates of emulsions, respectively; processes for manufacturing micelles, pre-concentrates of emulsions and products. | 2010-05-27 |
20100129454 | ABSORBENT COMPOSITION FOR SURFACE TREATMENT - The invention concerns an absorbent composition comprising: (a) at least 50 wt.-% of the overall composition have a particle size of less than 150 μm and are comprised of at least one absorbent component; and (b) at least 1.0 wt.-% of the overall composition have a particle size of at least 250 μm and are comprised of at least one particulate component, and its preferred uses. | 2010-05-27 |
20100129455 | NANOPARTICLE-DISPERSED FINE GLASS BEADS HAVING A CAVITY THEREIN, AND METHOD OF PRODUCING THE SAME - The present invention provides fine silicon-containing glass beads each having one or more cavities therein and containing nanoparticles in a glass phase of each of the silicon-containing glass beads, and a method of producing such glass beads, and also provides silicon-containing glass beads containing nanoparticles, which may be identical to or different from the nanoparticles in the glass phase, and a functional material such as pharmaceutical molecules (e.g., materials having fluorescent properties, magnetic properties, drug effects, etc.), and a method of producing such glass beads. | 2010-05-27 |
20100129456 | SUSTAINED-RELEASE NANOPARTICLE CONTAINING LOW-MOLECULAR-WEIGHT DRUG WITH NEGATIVELY CHARGED GROUP - A nanoparticle containing a low-molecular-weight drug having a negatively charged group is provided that is effectively targeted to an affected site, is capable of sufficiently sustained release of the drug, and has a reduced tendency to accumulate in the liver to cause reduced side effects. The nanoparticle containing a low-molecular-weight drug having a negatively charged group is obtained by hydrophobicizing the low-molecular-weight drug having a negatively charged group with a metal ion, and reacting the hydrophobicized drug with poly L-lactic acid or poly(L-lactic acid/glycolic acid) copolymer and poly DL- or L-lactic acid-polyethylene glycol block copolymer or poly(DL- or L-lactic acid/glycolic acid)-polyethylene glycol block copolymer. | 2010-05-27 |
20100129457 | Nanodiamond Enhanced Drugs | 2010-05-27 |
20100129458 | COMPOSITIONS AND METHODS FOR INHIBITING REPRODUCTION IN TADPOLE SHRIMP - Compositions, methods for forming compositions, and methods for using compositions for reducing tadpole shrimp populations in temporary pools using the hormone methyl farnesoate. Compositions can include a dry base having a bulk ingredient, a viscous additive having an oily compound, a saline solution, and preparation having an effective amount of phospholipid-encapsulated methyl farnesoate. The composition can be formed by combining the dry base and the viscous additive into a first mixture and adding all or a portion of the saline solution to form a crumbly consistency. Then, the methyl farnesoate preparation can be added. The composition may then be formed into a plurality of particles having shapes and sizes for consumption by the tadpole shrimp. In use, the particles may be dispensed prior to, or immediately after, the temporary pools are flooded with water. The particles may be formed such that they can withstand exposure to water for between about 4 to about 14 days. | 2010-05-27 |
20100129459 | BIODEGRADABLE MICROSPHERE COMPOSITION SUITABLE FOR THE CONTROLLED RELEASE OF GLUCOSE CONTROLLING PEPTIDE AND FORMULATION THEREOF - Disclosed are biodegradable microspheres, capable of releasing a glucose-regulating peptide in a controlled manner, comprising a biodegradable polymer carrier with the glucose-regulating peptide encapsulated therein, and methods for the preparation thereof. In addition to ensuring high encapsulation efficiency and high stability of the encapsulated drug, the microspheres shows neither an initial burst effect nor incomplete release and allows the zero-order release of drugs over a prolonged period of time, thus improving the therapeutic effect of the drug. | 2010-05-27 |
20100129460 | COMPOUNDS AND METHODS FOR PEPTIDE RIBONUCLEIC ACID CONDENSATE PARTICLES FOR RNA THERAPEUTICS - Compounds comprising condensed particles having diameters less than 1000 nm, wherein the particles comprise one or more double stranded ribonucleic acids (dsKNAs) and one or more peptides. The compounds, compositions and methods are useful for modulating gene expression by RNA Interference. | 2010-05-27 |
20100129461 | Process for Dispersing Amino Acids - A coated proteinaceous material can be produced by contacting the proteinaceous material with de-oiled phospholipids or mixtures thereof containing less than 20% triglycerides. The coating has between 0.1 and 1.5% by weight of the total proteinaceous material, of de-oiled lecithin. The proteinaceous material is hydrophobic, especially amino acids having a hydrophobicity of higher than 1.0 kJ/mol. In particular, the amino acids are leucine, isoleucine, valine, phenylalanine, tryptophan and/or methionine. The coated amino acids can be incorporated into food product and medicaments. | 2010-05-27 |
20100129462 | DECOLONIZING AGENT FOR HELICOBACTER PYLORI - The invention provides a decolonizing agent that can effectively decolonize | 2010-05-27 |
20100129463 | MULTI-FORMED COLLAGENOUS BIOMATERIAL MEDICAL DEVICE FOR USE IN WOUND CARE - The invention involves a submucosa tissue that has the capability of being shape formed or shape configured. The submucosa involves a purified form of submucosa tissue. Optionally, the submucosa can be packaged in such a manner to permit sterility or maintain sterility of the submucosa. | 2010-05-27 |
20100129464 | Manufacturing method and apparatus for producing substances that include negative hydrogen ion - A manufacturing method and apparatus produces various medium such as mineral substance, vitamin substance, or ceramic that include negative hydrogen icons for use by human beings and animals. In the manufacturing method, an optional mineral substance or vitamin substance as the medium in granular or powdered form is supplied to the inside of the container and filled with liquid hydrogen or hydrogen, gas. Then after leaving them in the container for a predetermined time, the medium is removed to be air dried, thereby producing the medium which is combined and included with negative hydrogen ion. Alternatively, high pressure, heat, or high voltage may be applied to the medium to contain the negative hydrogen ion in the medium. | 2010-05-27 |
20100129465 | Methods and Compositions Related to Acne Treatment - Disclosed herein are methods and compositions for treating acne using a composition comprising a large amount of naturally occurring minerals. | 2010-05-27 |
20100129466 | COMPOSITIONS AND METHODS FOR TREATING PLANTS - The invention is a method and composition for treating biofilm using a high valency silver ion. In preferred embodiments of the invention, the anti-biofilm agent is used to preserve, disinfect or treat plant material, including seeds, leaves, stems, vessels, flowers, roots and fruits, and any surface, particularly disinfecting work or processing surfaces and seed or plant surfaces; in anti-microbial coatings; and in treating human, plant, and animal diseases and conditions | 2010-05-27 |
20100129467 | Nutritional supplement - A nutritional supplement for inhibiting sensorineural hearing loss includes from about 0.25 to about 6.0 wt. % thiamin, from about 0.1 to about 10 wt. % pyridoxiyl-5-phosphate, from about 0.01 to about 10 wt. % folic acid, from about 0.025 to about 4.0 wt. % hydroxycobalamin, from about 1 to about 7 wt. % magnesium, from about 0.25 to about 6.0 wt. % zinc, from about 0.001 to about 0.02 wt. % selenium, from about 0.1 to about 10 wt. % manganese, from about 5 to about 50 wt. % ginger root P.E. 4:1, from about 5 to about 40 wt. % citrus bioflavonoids, from about 2.5 to about 40 wt. % 1-cystine, from about 5 to about 40 wt. % n-acetlyl-l-carnitine, from about 1 to about 40 wt. % alpha lipoic acid, from about 1 to about 40 wt. % coenzyme Q10, from about 1 to about 40 wt. % green tea extract, and from about 1 to about 60 wt. % resveratrol. | 2010-05-27 |
20100129468 | ANTIFUNGAL FOAM CONTAINING CICLOPIROXOLAMINE AND ZINC PYRITHIONE AND MEDICAL AND COSMETIC APPLICATIONS THEREOF - The invention relates to a composition in the form of an emulsion that can be expanded by an aerosol dispenser, characterised in that it comprises from 15 to 20 volume % of alcohol, from 1 to 10 volume % of C | 2010-05-27 |
20100129469 | USE OF DIMIRACETAM IN THE TREATMENT OF CHRONIC PAIN - The use of dimiracetam in the treatment of chronic pain is disclosed. At doses higher than those previously disclosed in relation with its cognition enhancing activity (i.e. amelioration of learning and memory), dimiracetam was able to completely revert hyperalgesia or allodynia associated with several animal models of chronic pain. Dimiracetam showed high activity in iatrogenic neuropathies associated with antiviral and chemotherapeutic drug treatments and in painful conditions caused by osteoarthritis. In addition, dimiracetam was devoid of toxicity even at doses 10-fold higher than the highest therapeutic dose. The possibility of treating such debilitating pathologies with a highly effective and essentially non-toxic compound is therefore disclosed. | 2010-05-27 |
20100129470 | METHOD OF TREATING BRAIN CANCER - Disclosed is (4-Methoxy-phenyl)-methyl-(2-methyl-quinazolin-4-yl)-amine hydrochloride effective as a cytotoxic agent. (4-Methoxy-phenyl)-methyl-(2-methyl-quinazolin-4-yl)-amine hydrochloride is useful in the treatment of a variety of clinical conditions in which uncontrolled growth and spread of abnormal cells occurs, and in particular to its use in treating brain cancer. | 2010-05-27 |
20100129471 | ISO CA-4 AND ANALOGUES THEREOF AS POTENT CYTOTOXIC AGENTS INHIBITING TUBULINE POLYMERIZATION - The invention relates to a compound of the formula (I) in which: R | 2010-05-27 |
20100129472 | Compositions And Method For The Treatment Of Acne - The present invention relates to methods for the treatment and reduction of acne and compositions comprising sulfur colloid and a 100% natural base. | 2010-05-27 |
20100129473 | AMINO SUBSTITUTED DIARYL[a,d]CYCLOHEPTENE ANALOGS AS MUSCARINIC AGONISTS AND METHODS OF TREATMENT OF NEUROPSYCHIATRIC DISORDERS - Disclosed herein are analogs of clozapine and pharmaceutically acceptable salts, esters, amides, or prodrugs thereof; methods of synthesizing the analogs; and methods of using the analogs for treating neuropsychiatric disorders. In some embodiments, the analogs are amino substituted diaryl[a,d]cycloheptenes. | 2010-05-27 |
20100129474 | AGRICULTURAL TREATMENT - A method for the control of microorganisms, fungi or oomycetes in agriculture, said method comprising applying to plants or to the environment thereof, an anti-microbial, anti-fungal or anti-oomycetes effective amount of a combination of: (i) an agriculturally acceptable acidifying agent, and (ii) an agriculturally acceptable source of nitrite ions or a nitrate precursor thereof, wherein the combination of (i) and (ii) acts as a source of nitric oxide. Systems and compositions for use in this method are also described and claimed. | 2010-05-27 |
20100129475 | ESSENTIAL OIL OF KUNZEA AMBIGUA AND METHODS OF USE - A method for treating disease includes the steps of obtaining the essential oil from the Kunzea ambigua plant and administering the essential oil obtained to a human to take internally. The essential oil of the Kunzea ambigua plant has been discovered to act positively against parasitic infestation of humans and animals, and also has been found to have high kill rates against various viral and bacterial infections. | 2010-05-27 |
20100129476 | COMPOSITION COMPRISING REHMANNIAE RADIX PREPARATA, NOTOGINSENG RADIX OR MIXTURE EXTRACT THEREOF FOR PREVENTING AND TREATING OF PERIODONTITIS AS AN EFFECTIVE COMPONENT - Disclosed is a pharmaceutical composition for the treatment and prevention of periodontal diseases, comprising an extract from | 2010-05-27 |
20100129477 | COMPOSITION FOR TREATMENT OF SKIN DISORDERS - A preparation for treating psoriasis vulgaris containing ascorbic acids and salts thereof, tartaric acid and vinegar, water and a carrier. A more potent preparation contains in addition vitamin B2 and several plant extracts. | 2010-05-27 |
20100129478 | Plant Extracts and Methods and Uses Therefore - The invention relates to compositions such as pharmaceutical compositions and comestibles comprising extracts of | 2010-05-27 |
20100129479 | PELLETIZING DIE PLATE, PELLETIZING DIE ASSEMBLY, AND METHOD FOR MAKING THE SAME - A pelletizing die plate is useful with a main die body with passageways. The pelletizing die plate includes a die plate body, which is made of a hard composite material. The hard composite material contains a low thermal conductivity matrix of hard matrix particles and an infiltrant alloy bonded to the hard matrix particles to form the hard composite material. The hard matrix particles includes between greater than zero and up to about 20 weight percent titanium carbide particles and the balance cast tungsten carbide particles. The infiltrant alloy contains at least one or more of nickel and copper. The hard matrix particles are between about 50 weight percent and about 70 weight percent of the hard composite material and the infiltrant alloy are between about 30 weight percent and about 50 weight percent of the hard composite material. The hard composite material has a thermal conductivity less than or equal to about 25 Watt/m° K. The die plate body has bores in alignment with the passageways in the main die body thereby forming continuations of the passageways of the main die body. A method of making a pelletizing die assembly that has the steps of: providing a main die body wherein the main die body having a first end face and a second end face, and a plurality of passageways extending through said main die body between said first and second end faces; placing a first mass of hard matrix particles on the second end face of the main die body; placing a second mass of infiltrant alloy on the first mass of hard matrix particles; heating the first mass and the second mass whereby the infiltrant alloy infiltrates the first mass to form a hard composite material comprising a solid mass of the hard matrix particles bonded together by the infiltrant alloy; and forming bores in the hard composite material to form a top die plate wherein the bores are in alignment with the passageways in the main die body. | 2010-05-27 |
20100129480 | MULTI-ANVIL CUBIC MACHINE COMPRISING HEMISPHERICAL PISTONS, WHICH IS USED TO GENERATE HIGH PRESSURES AND HIGH TEMPERATURES - The present invention provides a multi-anvil machine, more specifically, a multi-anvil cubic machine that generates substantially hydrostatic pressures and high temperatures inside an industrial reaction chamber. In said chamber materials such as diamonds, cubic boron nitride and similar materials. These conditions are attained in a stable and efficient manner. The generation of force is produced by hemispherical pistons having a short travel path and housed in semi-spherical chambers. The number of mobile components has been reduced in order to simplify and facilitate the assembly during each working cycle. | 2010-05-27 |
20100129481 | APPARATUS FOR MANUFACTURING FLOOR MAT USING DOUBLE CONVEYOR SYSTEM - The present invention relates to a double-conveyor type apparatus for manufacturing a floor mat adapted to be disposed on a floor surface in an operating room in an industrial site, in various buildings or vehicles, or in an office room or house so as to reduce the impact or load transmitted to a human body and to prevent the sliding thereon, wherein the double-conveyor type apparatus includes a double-conveyor system having upper and lower conveyors formed of a plurality of unit upper and lower molds standardized to a given size and in series connected to each other is operated to allow a material of the floor mat to be passed thereon, thereby manufacturing the floor mat, such that the mass production of the floor mat can be simply and rapidly achieved to enhance the productivity. | 2010-05-27 |
20100129482 | Intermittent flow extrusion process and food product - An extrusion process incorporates a forming manifold where a tubular flow of a second material is intermittently interrupted while a core flow of a first material is discharged substantially continuously. Subsequently, the core flow is severed to form individual food items or treats for humans, animals, and the like, where the tubular flow results in an outer component surrounding an inner component which protrudes from one or both ends of the outer component. Material of the core flow is bone-like, while material of the tubular flow is meat like. Material of the tubular flow may include material from the core flow subjected to mixing in a static mixer to achieve a marbled texture of the outer material. | 2010-05-27 |
20100129483 | INJECTION MOLDING MACHINE FOR PROCESSING PLASTICS MATERIALS - The invention relates to an injection moulding machine comprising a machine frame ( | 2010-05-27 |
20100129484 | MOLD SYSTEM FOR PRODUCING OPHTHALMIC DEVICES - A molding system for forming ophthalmic devices includes at least one mold half having a base wherein the at least one mold half is configured to be engaged by an injection molding machine, at least one insert retainer, the at least one insert retainer being configured to receive a plurality of inserts wherein each of the inserts is configured to receive thermoplastic material for forming at least one lens curve wherein the at least one mold half is configured to receive the at least one insert retainer, and means for attaching the at least one insert retainer to the at least one mold half. | 2010-05-27 |
20100129485 | Apparatus for molding cooked rice - Provided is a cooked rice molding apparatus which ensures that a formed cooked rice product falls while keeping almost the same posture without inclining. Part of a concave molding surface | 2010-05-27 |
20100129486 | Method and System for Double-Sided Patterning of Substrates - A system of patterning first and second opposed sides of a substrate is described. The system may employ a mold assembly and obtaining a desired spatial relationship between the first and second opposed sides of the substrate and the mold assembly. In a further embodiment, the method and system may employ a first and a second mold assembly. | 2010-05-27 |
20100129487 | MASS-LESS BELT MANDREL - This invention provides a mandrel used to produce belts where materials are cured onto a belt. Specific examples for illustration purposes are directed to a mandrel used to produce fuser belts for use in electrophotographic marking systems. The mandrel provides for reduced heating temperature during the curing heating step because the only mass required to be heated during curing is the belt and not the prior art solid mandrel. This provides significant advantages, such as faster cycle time, less energy, and less degrading of layer materials. The present mandrel comprises two terminal caps connected by threaded rods around which the belt is positioned for coating and curing. | 2010-05-27 |
20100129488 | CONTINUOUS FORMATION OF CENTER-FILLED GUM - The present invention provides a method for continuously producing pieces of liquid-filled gum material, including applying an anti-sticking agent to the rope of liquid-filled gum material before it is individually cut into pieces. The invention further provides for a liquid-filled chewing gum including a liquid-fill composition, and a gum region surrounding the liquid-fill composition, where the gum region includes an anti-sticking agent that reduces the tendency of the gum region to stick to the molds and operating machinery during gum manufacturing. | 2010-05-27 |
20100129489 | SENSATE-PLATED SANDING COMPOSITION AND PRODUCTS MADE THEREFROM - The present invention relates to sensate-plated sanding compositions, products containing the same and methods for preparing. More specifically, the compositions of the present invention may include a particulate and a sensate composition, which may include a flavor and/or functional component, associated with the particulate. | 2010-05-27 |
20100129490 | COMBINED BREWING SYSTEM - A combined brewing system for small scale brewing of fermented alcoholic beverages, particularly beer, and to a method of making fermented alcoholic beverages. The brewing system comprises a single pressurizable vessel. The beer is naturally carbonated to the desired level during fermentation. Sediment is collected and substantially separated from within the vessel and removed from the vessel while the vessel is under pressure. Compressed gas is added for maintaining natural carbonation levels, so that the contents of the vessel can be drawn off at a desired pressure. The vessel has a temperature control system to selectively control the temperature during processing. | 2010-05-27 |
20100129491 | Tryptophan transporter gene and use thereof - The present invention relates to a tryptophan transporter gene and to uses of the gene. The invention relates in particular to a brewer's yeast which can control the tryptophan assimilation ability, alcoholic beverages produced using such yeast, and a method of producing such alcoholic beverages. More specifically, the invention relates to a yeast which can control the tryptophan assimilation ability by controlling the level of expression of the TAT2 gene which codes for the tryptophan transporter Tat2p in brewer's yeast, particularly of the nonScTAT2 gene characteristic to beer yeast, and to a method of producing alcoholic beverages using such yeast. | 2010-05-27 |
20100129492 | COLLAPSIBLE BREAD DOUGH RISING BOX - A collapsible bread dough rising box is disclosed that can be assembled for warming bread dough during rising, and then collapsed into a folded middle section held between a top member and bottom for easy transport and storage. The box can be large enough to hold a large mixing bowl or several bread pans. A multi-position switch or thermostat can be used to maintain the internal temperature at a desired value between 80 and 120 degrees Fahrenheit. Ventilation channels can be cooperative with the thermostat. Lights can indicate power on, heater on, desired temperature reached and/or safety mechanism activated. Hinges can connect the top member and the middle member to the bottom, for easy assembly and folding. The box is affordable for home bakers. In preferred embodiments the middle is composed of molded plastic panels and living hinges that snap together, thereby further minimizing the cost. | 2010-05-27 |
20100129493 | Low Sugar Yoghurt - A yoghurt comprises: a fat phase comprising conjugated linoleic acid or a derivative thereof (CLA); fruit; and sugar in an amount of less than 7.5% per weight. Preferably, the yoghurt has an energy content of less than 100 kcal/100 g. | 2010-05-27 |
20100129494 | Yoghurt - A yoghurt comprises pinolenic acid or a derivative thereof. The yoghurt may be produced by:
| 2010-05-27 |
20100129495 | SERUM CHOLESTROL-LOWERING MATERIAL, PROCESS FOR PRODUCING SAME - The serum cholesterol-lowering material of the invention contains lactic acid-fermented egg white. The food composition having a serum cholesterol-lowering effect of the invention contains a serum cholesterol-lowering material. The pharmaceutical composition having a serum cholesterol-lowering effect of the invention contains a serum cholesterol-lowering material as an active component. The process for producing the serum cholesterol-lowering material of the invention comprises adding | 2010-05-27 |
20100129496 | NUTRITIONAL FORMULATIONS - This invention relates to novel nutritional supplements comprising essential fatty acids and iron, as well as methods related thereto. | 2010-05-27 |
20100129497 | USE OF NOVEL CARBOHYDRATES AND CARBOHYDRATE BLENDS TO PROVIDE A SPORTS BEVERAGE WITH INCREASED ABSORPTION - A carbohydrate blend is provided, including at least fructose and glucose. Some or all of the glucose may be provided by glucooligosaccharides having a structure containing up to ten degrees of saccharide polymerization. An aqueous solution having 6% by weight of the carbohydrate blend has a measured osmolality of 230-300 mOsm/kg. Further, the measured osmolality of the carbohydrate solution is substantially stable during storage for up to six months. Also, a rehydration/sports beverage composition is provided, including water, a carbohydrate blend, electrolytes, and optionally edible acids, coloring agents, flavoring agents and the like. The beverage composition may have a measured osmolality of about 230-260 mOsm/kg, which provides faster absorption by the gastrointestinal system of a subject than a beverage composition with a higher osmolality. | 2010-05-27 |
20100129498 | Intermittent flow extrusion process and food product - An extrusion process incorporates a forming manifold where a tubular flow of a second material is intermittently interrupted while a core flow of a first material is discharged substantially continuously. Subsequently, the core flow is severed to form individual food items or treats for humans, animals, and the like, where the tubular flow results in an outer component surrounding an inner component which protrudes from one or both ends of the outer component. Material of the core flow is bone-like, while material of the tubular flow is meat like. Material of the tubular flow may include material from the core flow subjected to mixing in a static mixer to achieve a marbled texture of the outer material. | 2010-05-27 |
20100129499 | BREADS - A bread having good texture, brightness and flavor is provided despite inclusion of a great deal of catechins. | 2010-05-27 |
20100129500 | METHOD OF PREPARING A COATED CONFECTIONARY PRODUCT - A method of producing a confectionary product includes providing a chewy material including a first sweetener and a fat. The chewy material is mixed in a mixing device and metered through a pumping device. A candy material including a second sweetener is disposed around the chewy material to form a jacketed confectionary material. The jacketed confectionary material is formed into a confectionary product. | 2010-05-27 |
20100129501 | METHODS AND COMPOSITIONS FOR PRESERVING EGG PRODUCTS - Methods and compositions for inhibiting | 2010-05-27 |
20100129502 | Food tray device and method - A food tray device for maintaining food warm or cold is disclosed. The food tray device has a support and a disposable tray portion or container. The container generally does not need to be sturdy enough to reliably carry food without the support. Optionally the support and container may have holes for limited venting of the tray interior while maintaining the moisture content of the food. | 2010-05-27 |
20100129503 | PACKAGES FOR STEAM VENTING, AND METHODS - A “freezer to microwave oven” package ( | 2010-05-27 |
20100129504 | NOVEL METHOD FOR PREPARING A FOOD PRODUCT - The invention relates to a novel method for preparing a sliced food product comprising a low amount of acrylamide. The food product is preferably of plant origin, such as a tuber or a vegetable, preferably the food product is potato-based. The invention also relates to the use of a short heat treatment to accelerate low temperature extraction of asparagine from an asparagine-containing sliced food intermediate. | 2010-05-27 |
20100129505 | DYED AND FLAVORED GELS FOR CO-EXTRUSION - A composition of an edible collagen and a method of its preparation useful for manufacturing edible enclosures or casings for food products that possess a desired color and flavor profile, such as deemed useful for cheese or sausage casings. | 2010-05-27 |
20100129506 | METHOD AND APPARATUS FOR CONTINUOUS PROCESSING OF WHOLE MUSCLE MEAT PRODUCTS - A continuous method and system for processing whole muscle meat employs a mixer housing having a pair of parallel rotating shafts located therein. The parallel rotating shafts have a plurality of mixing elements thereon, such as frustoconical elements, blocking elements, or ellipsoid elements. The mixer housing has an input end to receive the meat ingredients, such as meat pieces, salt solution, water, preservatives, and other additives such as spices. The mixer housing has an output, which is separated a distance from the input, such that the output discharges the whole muscle meat product. As the ingredients including the meat move from the input to the output along the shafts, the mixing elements work the meat with the other ingredients thereby increasing ingredient incorporation including diffusion of the salt solution into the whole muscle meat pieces. | 2010-05-27 |
20100129507 | Edible Adhesive Coatings For Multi-Component Food Products - This invention relates to edible adhesive coatings for multi-component food products, methods of making edible adhesive coatings, food products comprising these edible adhesive coatings, and methods to make multi-component food products comprising edible adhesive coatings; and particularly to edible adhesive coatings for multi-component food products, methods of making edible adhesive coatings, food products comprising these edible adhesive coatings, and methods to make multi-component food products comprising edible adhesive coatings where one of the functions for the edible adhesive coating is to facilitate adhesion of particulate components, such as grains or granola pieces, to a base component, such as a food-based center. This invention, in one embodiment, provides an edible adhesive coating comprising a source of edible fat, a hygroscopic food powder, and optionally an emulsifier. In specific embodiments, the hygroscopic food powder is a dietary fiber, such as polydextrose, and the emulsifier is lecithin. The source of edible fat can be any typical source, including compound coatings and chocolate coatings. Other embodiments of the present invention provide methods to make edible adhesive coatings, methods to make food products using edible adhesive coatings, and food products comprising edible adhesive coatings. | 2010-05-27 |
20100129508 | Coating of Confectionery and Tablets - A method of coating an edible item. The method comprises applying molten polyol to the item and cooling the polyol to crystallise it into its solid form. | 2010-05-27 |
20100129509 | NATURAL PRODUCT EXTRACTION - In a method for extracting products of value from animal or vegetable starting material, a solution is to be created, with which extraction is improved, with regard to both the yield and separation of natural products to be extracted, and management of the method. | 2010-05-27 |
20100129510 | Beverage Composition - A beverage composition comprises fat, protein and water, said fat comprising at least 5% by weight of pinolenic acid or a derivative thereof. | 2010-05-27 |
20100129511 | RETORTING APPARATUS AND METHOD - An apparatus for the heat treatment of a product, especially a food product such as a food product contained within a hermetically sealed container or pouch of plastics or like material, for example for sterilization, pasteurization or cooking, having a heating unit to bring product from ambient towards a heat treatment temperature and pressure; a retort unit to apply a heat treatment to a product; and a cooling unit to allow product to be brought down from heat treatment temperature and pressure towards ambient; wherein each unit and retort is selectably sealable from the others and from ambient conditions. | 2010-05-27 |
20100129512 | Method for Preparing a Drink and Apparatus and Capsule for Application of This Method - A method for preparing a drink by passing hot water in a capsule ( | 2010-05-27 |
20100129513 | DEVICE FOR MAKING TEXTURED PORTIONS OF FOOD PRODUCTS - This invention relates to a device for producing portions of food products in pieces, especially chunks of fresh meat, comprising at least one pump capable of outputting an approximately constant flow rate of food product in pieces, a tubular distributing pipe ( | 2010-05-27 |
20100129514 | METHOD AND APPARATUS FOR CONTINUOUS PROCESSING OF WHOLE MUSCLE MEAT PRODUCTS - A continuous method and system for processing whole muscle meat employs a mixer housing having a pair of parallel rotating shafts located therein. The parallel rotating shafts have a plurality of mixing elements thereon, such as frustoconical elements, blocking elements, or ellipsoid elements. The mixer housing has an input end to receive the meat ingredients, such as meat pieces, salt solution, water, preservatives, and other additives such as spices. The mixer housing has an output, which is separated a distance from the input, such that the output discharges the whole muscle meat product. As the ingredients including the meat move from the input to the output along the shafts, the mixing elements work the meat with the other ingredients thereby increasing ingredient incorporation including diffusion of the salt solution into the whole muscle meat pieces. | 2010-05-27 |
20100129515 | FLAVOUR MODULATING SUBSTANCES - The present invention in a first aspect relates to flavour modulation in foodstuffs, beverages, tobacco products and oral care products, using a flavour modulating substance selected from the group represented by formula (I), edible salts thereof and edible esters thereof. It has been found that these substances are capable imparting highly desirable taste attributes in the products they are incorporated in. In addition said flavour modulating substances are capable of modulating and complementing, the sensory impact of other, taste imparting, substances. Thus, the present substances are advantageously applied in flavour compositions, foodstuffs, tobacco products and oral care products. Typical examples of flavour modulating substances according to the present invention include N-vanillyl urea, N-vanillyl thiourea, N-vanillyl guanidine, N-isovanillyl urea, N-(3-ethoxy-4-hydroxybenzyl) urea, N-(3,4 dimethoxybenzyl) urea, N,N′-divanillyl urea, N,N′-divanillyl thiourea, N-octyl-N′-vanillyl urea, N-octyl-N′-vanillyl thiourea, N-hexyl-N′-vanillyl urea, N-hexyl-N′-vanillyl thiourea, N-decyl-N′-vanillyl urea, N-decyl-N′-vanillyl thiourea, N-benzyl-N′-vanillyl urea, N-benzyl-N′-vanillyl thiourea, edible salts thereof and edible esters thereof. | 2010-05-27 |
20100129516 | FLAVORING SUBSTANCE-INCLUDED CELLULOSE - The present invention concerns a flavoring substance-included cellulose, comprising or consisting of cellulose and flavoring substances included in the cellulose, methods for producing such flavoring substance-included celluloses, and mixtures comprising flavoring substance according to the invention. | 2010-05-27 |
20100129517 | REDUCING THE SENSORY COOLING EFFECT OF POLYOLS - The present invention relates to the use of fibers and/or sugar esters to reduce the sensory cooling effect of polyols, in particular, erythritol. | 2010-05-27 |
20100129518 | METHOD OF OIL PURIFICATION, AND USES THEREOF FOR FOOD AND FEED - The current invention describes a new process of purifying oils. In particular, the present invention relates to a method which combines treatment with ad- or absorbing agents (AAs) and a membrane-based process for separating the oil from the contaminated AAs. Further, the present invention relates to the use of active carbon and membrane filtration for purifying oil and the use of purified oil as food or feed ingredients. | 2010-05-27 |
20100129519 | High-Fat Cocoa Product, A Process For Its Manufacture And Its Application In Confections - Cocoa liquor is subjected to a process whereby the cocoa butter is immobilized by the cocoa solids. This is achieved by forming a suspension of cocoa liquor in an aqueous medium and removing the aqueous medium component of the suspension. The resulting processed cocoa liquor does not leach cocoa butter when subjected to a temperature of 50° C. overnight. The processed cocoa liquor is a useful ingredient in the food industry. It is a particularly useful ingredient for food stuffs where cocoa butter migration causes fat bloom. Replacement of standard cocoa liquor with the processed cocoa liquor of the invention greatly reduces fat bloom in confectionery products. | 2010-05-27 |
20100129520 | METHOD AND APPARATUS FOR CONTINUOUS PROCESSING OF WHOLE MUSCLE MEAT PRODUCTS - A continuous method and system for processing whole muscle meat employs a mixer housing having a pair of parallel rotating shafts located therein. The parallel rotating shafts have a plurality of mixing elements thereon, such as frustoconical elements, blocking elements, or ellipsoid elements. The mixer housing has an input end to receive the meat ingredients, such as meat pieces, salt solution, water, preservatives, and other additives such as spices. The mixer housing has an output, which is separated a distance from the input, such that the output discharges the whole muscle meat product. As the ingredients including the meat move from the input to the output along the shafts, the mixing elements work the meat with the other ingredients thereby increasing ingredient incorporation including diffusion of the salt solution into the whole muscle meat pieces. | 2010-05-27 |
20100129521 | Heat Processed Products Having Altered Monomer Profiles and Processes For Controlling The Epimerization of (-)-Epicatechin and (+)-Catechin In The Products - A method for controlling the epimerization of (−)-epicatechin to (−)-catechin in an epicatechin-containing product, preferably an edible product, or of (+)-catechin to (+)-epicatechin in a catechin-containing product, comprises the step of heating the product at a temperature of up to about 200° C. and at a pH of up to about 8. Under either method, the epimerization may be carried out in an open food processor in a reduced oxygen atmosphere or in a closed food processor. The edible product may be pasteurized, boiled, or sterilized during the epimerization. Epimerization is minimized by lowering the heating temperature, by lowering the pH, and/or by lowering the heating time. Conversely, the epimerization is maximized by increasing the heating temperature, by increasing the pH, and/or by increasing the heating time. The edible product may contain or be a fruit product, a vegetable product, a cereal product, a bean product, a nut product, a spice product, or a botanical product. | 2010-05-27 |
20100129522 | CAFFEINATED FROZEN CONFECTIONS - The present invention is related to a caffeinated freeze pop product. Specifically, the mixture for the freeze pop includes water, sweetener, preservatives, caffeine, citric acid, flavoring agent, and a coloring agent. The sweetener can be any type of sweetener but is preferably high fructose corn syrup, and the preservatives generally are sodium benzoate, potassium sorbate, and adenosine monophosphate. The flavoring agent can be of any flavor, and include: cherry, orange, blue raspberry, tropical fruit, sour apple, and wild berry. Further the color of the caffeinated freeze pops can be any color, including: red, orange, blue, purple, yellow, and green. Generally the method of making the freeze pop is to dissolve the preservatives into the water; then combining in the citric acid, caffeine, and sweetener; and last combining the caffeinated mixture with flavoring and coloring agents for visual and taste appeal. | 2010-05-27 |
20100129523 | IOL INSERTION APPARATUS AND METHODS FOR MAKING AND USING SAME - Apparatus, and methods of making and using apparatus, for inserting intraocular lenses (IOLs) are disclosed. The apparatus includes a hollow tube having an interior wall defining a hollow space through which an intraocular lens may be passed from the open space into an eye. A lubricity enhancing component is covalently bonded to the hollow tube at the interior wall in an amount effective to facilitate the passage of the intraocular lens through the hollow space. The lubricity enhancing component includes a substituent component effective to reduce hydrolysis of said lubricity enhancing component relative to an identical lubricity enhancing component without the substituent component. | 2010-05-27 |
20100129524 | METHODS OF DISPENSING POWDER COATING COMPOSITIONS AND ARTICLES COATED THEREWITH - Disclosed are methods of dispensing thermoset powder coating compositions comprising a colorant, a particulate film-forming resin, and a curing agent for the film-forming resin, methods of coating substrates with powder coating compositions dispensed according to such methods, and systems for dispensing such powder compositions. | 2010-05-27 |
20100129525 | APPARATUS FOR FORMING PHOSPHOR LAYER AND METHOD FOR FORMING PHOSPHOR LAYER USING THE APPARATUS - A phosphor layer forming apparatus ( | 2010-05-27 |
20100129526 | SUBSTRATE PROCESSING APPARATUS - A method of processing a substrate in a substrate processing apparatus that is arranged adjacent to an exposure device and includes first, second and third processing units, includes the steps of forming a film made of a photosensitive material on the substrate by said first processing unit before exposure processing by said exposure device. The method also includes applying drying processing to the substrate by said second processing unit after the exposure processing by said exposure device and applying development processing to the substrate by said third processing unit after the drying processing by said second processing unit | 2010-05-27 |
20100129527 | MANUFACTURING METHOD AND MANUFACTURING APPARATUS FOR IMAGE DISPLAY ELEMENT STRUCTURE, AND MANUFACTURING METHOD AND MANUFACTURING APPARATUS FOR ELECTROPHORETIC IMAGE DISPLAY ELEMENT - A disclosed method of manufacturing an image display element structure includes a coating step of coating a substrate surface including a plurality of recessed portions arranged at predetermined intervals, with a coating material that is plastic-deformable, in such a manner as to maintain spaces in the recessed portions; and an expanding step of forming gaps in the coating material coating the substrate surface by expanding gas in the spaces, wherein the gaps correspond to the recessed portions; and a peeling step of peeling off the coating material in which the gaps have been formed, from the substrate surface. | 2010-05-27 |
20100129528 | DISPLAY DEVICE AND METHOD OF FABRICATING THE SAME - A constitution of the display device of the invention is shown in the following. The display device includes a pixel unit including TFTs of which the active layer contains an organic semiconductor material for forming channel portions in the opening portions in an insulating layer arranged to meet the gale electrodes. The pixel unit further includes a contrast media foamed on the electrodes connected to the TFTs for changing the reflectivity upon the application of an electric field, or microcapsules containing electrically charged particles that change the reflectivity upon the application of an electric field. The pixel unit is sandwiched by plastic substrates, and barrier layers including an inorganic insulating material are provided between the plastic substrates and the pixel unit. The purpose of the present invention is to supply display devices which are excellent in productivity, light in weight and flexible. | 2010-05-27 |
20100129529 | Method For Manufacturing A Nanoparticle, Method For Manufacturing A Light-Emitting Element Having The Nanoparticle, And Method For Manufacturing A Display Substrate Having The Nanoparticle - In a method for manufacturing a nanoparticle, a precursor (e.g., transition metal complex) mixed with polyethylene glycol (PEG) is thermally decomposed. A nanoparticle is formed from the thermal decomposition. PEG is cost effective and less toxic than chemicals that are conventionally used for nanoparticle production, so that costs for manufacturing the nanoparticle may be decreased. Further, PEG may be reused to produce more nanoparticles. | 2010-05-27 |